Title |
Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial
|
---|---|
Published in |
Intensive Care Medicine, January 2013
|
DOI | 10.1007/s00134-013-2814-2 |
Pubmed ID | |
Authors |
Philippe Vignon, Pierre-François Dequin, Anne Renault, Armelle Mathonnet, Nicolas Paleiron, Audrey Imbert, Delphine Chatellier, Valérie Gissot, Gwenaelle Lhéritier, Victor Aboyans, Gwenael Prat, Denis Garot, Thierry Boulain, Jean-Luc Diehl, Luc Bressollette, Aurélien Delluc, Karine Lacut, The Clinical Research in Intensive Care and Sepsis Group (CRICS Group) |
Abstract |
Venous thromboembolism (VTE) is a frequent and serious problem in intensive care units (ICU). Anticoagulant treatments have demonstrated their efficacy in preventing VTE. However, when the bleeding risk is high, they are contraindicated, and mechanical devices are recommended. To date, mechanical prophylaxis has not been rigorously evaluated in any trials in ICU patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | <1% |
Germany | 1 | <1% |
France | 1 | <1% |
Belgium | 1 | <1% |
Unknown | 108 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 14% |
Student > Master | 13 | 12% |
Student > Postgraduate | 12 | 11% |
Other | 11 | 10% |
Student > Bachelor | 9 | 8% |
Other | 21 | 19% |
Unknown | 30 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 60 | 54% |
Nursing and Health Professions | 5 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Sports and Recreations | 2 | 2% |
Philosophy | 1 | <1% |
Other | 7 | 6% |
Unknown | 34 | 30% |